Article PDF first page preview

First page of Research progress of autophagy in the pathogenesis of bronchial asthma

Asthma is a complex chronic inflammatory disease of the airways characterized by chronic airway inflammation, hyperreactivity, and remodeling. Autophagy is responsible for lysosomal degradation through intracellular degradation when the proteasome cannot destroy damaged cytoplasmic organelles and proteins. Plenty of studies have shown that both impaired and overactive autophagic processes concern the pathogenesis of cancers, neurodegenerative diseases, metabolically associated diseases, and immune system diseases. Autophagy also plays both protective and damaging roles in the pathogenesis of asthma. To better understand the pathogenesis of asthma, this review will concentrate on the roles that autophagy plays in airway inflammation, immunological response, and remodeling. It will cover new advances and potential therapies on the role of autophagy in the onset and development of human asthma. This will contribute to the strategy for developing new targets to treat this disease.

Journal Section:
Clinical Immunology
This content is only available via PDF.
S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2025
You do not currently have access to this content.